TownSquare Capital’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,104
Closed -$40.9K 1295
2023
Q4
$40.9K Sell
14,104
-13,758
-49% -$21.7K ﹤0.01% 1113
2023
Q3
$37.6K Sell
27,862
-49,544
-64% -$86.8K ﹤0.01% 1084
2023
Q2
$166K Sell
77,406
-10,990
-12% -$26.7K ﹤0.01% 1009
2023
Q1
$257K Sell
88,396
-1,045
-1% -$5.27K 0.01% 869
2022
Q4
$614K Sell
89,441
-9,587
-10% -$45.3K 0.02% 579
2022
Q3
$314K Buy
99,028
+59,250
+149% +$215K 0.01% 573
2022
Q2
$128K Buy
39,778
+4,060
+11% +$11.8K ﹤0.01% 688
2022
Q1
$108K Buy
35,718
+10,020
+39% +$33.9K ﹤0.01% 684
2021
Q4
$115K Sell
25,698
-3,073
-11% -$15K ﹤0.01% 694
2021
Q3
$189K Buy
28,771
+18,193
+172% +$174K 0.01% 673
2021
Q2
$153K Buy
+10,578
New +$146K ﹤0.01% 594

Other funds holding STIM

TownSquare Capital's STIM Position: Q1 2024 in Review

TownSquare Capital sold out of Neuronetics (STIM) in Q1 2024, closing a stake of 14,104 shares — an estimated $40.9K sold.

TownSquare Capital first reported a position in STIM in Q2 2021 and held it in 11 quarters. The position peaked at $614K in Q4 2022. 66 funds tracked by Wall St. Rank hold STIM as of Q1 2024.

  • TownSquare Capital reported no remaining Neuronetics position as of Q1 2024 after selling out during the quarter.
  • TownSquare Capital sold 14,104 Neuronetics shares in Q1 2024, an estimated $40.9K.
  • TownSquare Capital first reported a position in Neuronetics in Q2 2021 and held it in 11 quarters.
  • TownSquare Capital's Neuronetics position peaked at $614K in Q4 2022.
  • 66 funds tracked by Wall St. Rank held Neuronetics as of Q1 2024.

Based on TownSquare Capital's 13F filing for Q1 2024, filed 15 May 2024.